Dare Bioscience DARE will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Dare Bioscience to report an earnings per share (EPS) of $-0.63.
Anticipation surrounds Dare Bioscience's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
During the last quarter, the company reported an EPS beat by $0.16, leading to a 9.96% drop in the share price on the subsequent day.
Here's a look at Dare Bioscience's past performance and the resulting price change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | -0.71 | -0.72 | -1.20 | |
EPS Actual | -0.55 | 1.52 | -0.84 | -0.72 |
Price Change % | -10.0% | 20.0% | 14.000000000000002% | -11.0% |
Market Performance of Dare Bioscience's Stock
Shares of Dare Bioscience were trading at $2.89 as of March 27. Over the last 52-week period, shares are down 50.45%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Dare Bioscience visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.